Universal Detection Technology to Present at the World Trade Week at the Port of Hueneme on May 25, 2005.LOS ANGELES -- Universal Detection Technology (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :UDTT) announced today that it will be presenting its bacterial spore monitor, BSM-2000, used for detection of endospores such as anthrax, at the World Trade Week conference at the Port of Hueneme on May 25, 2005. The conference is a joint effort by the Port of Hueneme, Pierce College International Business Center, Southern California Regional District Export Council, Oxnard World Trade Center, Oxnard College CITD CITD Centers for International Trade Development , Gold Coast SBDC SBDC Small Business Development Center SBDC South Bucks District Council (UK) SBDC Small Business Development Company (Trinidad and Tobago) SBDC Simulation Based Design Center , The US Commercial Service, The World Affairs Council World Affairs Council may refer to:
The special event at the Port of Hueneme will cover topics including export controls, security and the security industry and foreign trade zones. The conference will also provide UDTT's senior management team an opportunity to meet with potential partners and experts from various agencies. UDTT will be presenting BSM-2000 to potential partners and customers from the Port and various other agencies. "Our goal is to demonstrate the application of our endospore en·do·spore n. 1. A small spore formed within the vegetative cells of some bacteria. 2. A fungus spore borne within a cell or within the tubular end of a sporophore. 3. The inner layer of the wall of a spore. detection technology, developed in collaboration with JPL (language) JPL - JAM Programming Language. . We believe that ports are one of the prime targets for a bio-terrorist attack, vulnerable both as an actual target and as a hub for bringing lethal bio-agents into the homeland. Our technology can substantially increase the effectiveness of security infrastructure for ports, airports and other large public places," says Jacques Tizabi, UDTT's chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . About Universal Detection Technology Universal Detection Technology (UDT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Management believes that the Company's technology, together with third party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory “JPL” redirects here. For other uses, see JPL (disambiguation). Jet Propulsion Laboratory (JPL) is a NASA research center located in the cities of Pasadena and La Cañada Flintridge, near Los Angeles, California, USA. (JPL) has developed a bio-terror 'smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://udtt.invrel.net or http://www.udetection.com. Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the Company's filings with the Securities and Exchange Commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion